Results 141 to 150 of about 13,334 (226)

A meta-analysis of the effects of community-based treatments for asthma in children. [PDF]

open access: yesBMC Pediatr
Li Y   +7 more
europepmc   +1 more source

Degradation of Bronchodilator Agents in Oxymix System

open access: closedJournal of Pharmaceutical Sciences, 1973
Abstract: Known amounts of isoproterenol, phenylephrine, and epinephrine were added to the aqueous oxymix system and thereby exposed to potential redox destruction. Thirty minutes later, recoveries of isoproterenol and phenylephrine were 89-100% and 89-108%, respectively, while the recovery of epinephrine was 53-79%.
G H, Kronberg, B H, Takman
openaire   +3 more sources

Sympathomimetic agents and bronchodilators

open access: closed, 1979
D. E. Hathway, L. G. Dring, P. Millburn
openaire   +2 more sources

[Bronchodilator agents].

open access: closedLa Revue du praticien, 1990
J, Marsac, F, Vlastos
openaire   +2 more sources

New isoquinolines as potential bronchodilator agents

Tetrahedron, 1973
Abstract The syntheses of 5-hydroxy-6-hydroxymethyl, 6-hydroxy-7-hydroxymethyl and 7-hydroxy-6-hydroxymethyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolines ( 1d ), ( 1b ) and ( 1c ) respectively, are described.
S.F. Dyke, A.W.C. White, D. Hartley
openaire   +1 more source

Humidification, Nebulization, and Bronchodilator Agents

1978
These defense mechanisms include: (a) ciliary escalator system—the mucus carpet carrying microorganisms and small foreign particles at a normal rate of about 1 cm/min from bronchioles and bronchi to the larynx entrance, (b) coughing, and (c) phagocytosis—macrophages in alveoli clearing via interstitial spaces (lymphatics) and upward via the ciliary ...
openaire   +1 more source

In vitro studies on the relative potency of bronchodilator agents

Lung, 1985
This study describes a rapid in vitro assay for the order of potency of bronchodilator drugs using specific binding of (−)-[3H] dihydroalprenolol ([3H]DHA) to rat lung membranes. Under linear conditions with respect to tissue, specific binding of [3H]DHA showed saturability, rapid kinetics of association and dissociation of radioligand, and ...
J H, Fleisher, J L, Pinnas
openaire   +2 more sources

[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2004
Poor clearance of airway secretions contributes to the pulmonary disease in cystic fibrosis (CF). Bronchodilator therapy might benefit in CF, but the efficacy is controversial. Effects of mucolytic agents have not been demonstrated conclusively. Only, efficacy of recombinant human deoxyribonuclease (rhDNase) is established with a rapid onset of benefit.
P, Le Roux, B, Le Luyer
openaire   +1 more source

Home - About - Disclaimer - Privacy